Energex Systems Inc. announced that it has notified the FDA of its interest in applying for an Emergency Use Approval that would permit the company to offer its HemoModulation therapy for the treatment of type A, H1N1, otherwise known as swine flu. HemoModulation therapy was shown to inactivate the virus in mice.
SMARTANALYST, Inc., a pioneer in providing global strategic research and analytics solutions to Pharmaceutical and Biotech companies has discovered, based on therapeutic area analysis, a critical lack of information and communication to the general public on the treatment options for the current H1N1 flu, also known as the misnamed "Swine Flu" outbreak.
The Health Protection Agency is working with Torbay Care Trust and local authorities following the earlier confirmation of a case of swine flu in a pupil at a college in Paignton. As a precautionary measure, acting under advice from local health protection experts, the college will close at the normal time today and remain closed for seven consecutive days.
Three patients under investigation in England have been confirmed with swine flu, bringing the current total number of confirmed UK cases to five. Testing of the swine flu virus was carried out by the Health Protection Agency's Centre for Infections Virus Reference Department.
The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule on April 28, 2009 that would update payment rates and clarify the framework for Medicare patient selection and care in inpatient rehabilitation facilities (IRFs) during fiscal year (FY) 2010.
SOUTHAMPTON today joins a unique chain of Cancer Research UK Centres that are being launched across the UK. These Cancer Centres will draw together world class research and areas of medical expertise to provide the best possible results for cancer patients nationwide.
Taking aspirin in your 40s could cut the risk of cancer developing later in life, according to research published in the Lancet Oncology. In a detailed review of all the available evidence*, Cancer Research UK scientists suggest that taking aspirin at an age before cancer begins to develop - and for at least 10 years - would maximise the drug's potential to prevent cancer.
This year's MS Week is set to be one of the most memorable of awareness weeks for multiple sclerosis (MS) after a number of significant drug announcements. Scientists specialising in MS and presenting at the annual American Academy of Neurology convention in Seattle have reported research findings that take the field of MS treatments to a "new dawn".
New trial results presented at the American Academy of Neurology (AAN) congress and released today show the Novartis multiple sclerosis (MS) tablet FTY720 (fingolimod) to be potentially beneficial for people with relapsing-remitting MS.
The membership of the American Roentgen Ray Society (ARRS) voted overwhelmingly to approve a strategic integration with the American College of Radiology (ACR).
